Testosterone Replacement Therapy for Assessment of Long-term Vascular Events and Efficacy ResponSE in Hypogonadal Men (TRAVERSE) Study
The TRAVERSE (Testosterone Replacement therapy for Assessmentof long-term Vascular Events and efficacy ResponSE in hypogonadal men) is a Phase 4, randomized, double-blinded, placebo-controlled, multicenter study